Pacira to Report First Quarter 2021 Financial Results on Tuesday May 4, 2021
Pacira BioSciences, Inc. (NASDAQ:PCRX) will release its first quarter financial results on May 4, 2021, before U.S. markets open.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Pacira BioSciences, Inc. (NASDAQ:PCRX) will release its first quarter financial results on May 4, 2021, before U.S. markets open. The company will host a live conference call at 8:30 a.m. ET to discuss these results. Interested parties can participate by dialing 1-877-845-0779 (domestic) or 1-720-545-0035 (international) with passcode 8238109. The call will be available for replay for one week. Pacira is known for its commitment to non-opioid pain management, notably through its long-acting analgesic EXPAREL® and the iovera°® cryoanalgesia device.
Positive
- Commitment to non-opioid pain management solutions.
- Commercial success of EXPAREL® since its launch in April 2012.
- Acquisition of the iovera°® system enhances product offerings.
Negative
- None.
Details
News Market Reaction – PCRX
The recorded move for PCRX in the trading session of this news was +3.91%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
PARSIPPANY, N.J., April 21, 2021 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (NASDAQ:PCRX) today announced that it will report its first quarter financial results before the open of the U.S. markets on Tuesday, May 4, 2021. Following the release, the company will host a live conference call and webcast at 8:30 a.m. ET.
To participate in the conference call, dial 1-877-845-0779 and provide the passcode 8238109. International callers may dial 1-720-545-0035 and use the same passcode. In addition, a live audio of the conference call will be available as a webcast. Interested parties can access the event through the “Events” page on the Pacira website at investor.pacira.com.
For those unable to participate in the live call, a replay will be available at 1-855-859-2056 (domestic) or 1-404-537-3406 (international) using the passcode 8238109. The replay of the call will be available for one week from the date of the live call. The webcast will be available on the Pacira website for approximately two weeks following the call.
About Pacira
Pacira BioSciences, Inc. (Nasdaq: PCRX) is the industry leader in its commitment to non-opioid pain management and regenerative health solutions to improve patients’ journeys along the neural pain pathway. The company’s long-acting local analgesic, EXPAREL® (bupivacaine liposome injectable suspension) was commercially launched in the United States in April 2012. EXPAREL utilizes DepoFoam®, a unique and proprietary product delivery technology that encapsulates drugs without altering their molecular structure, and releases them over a desired period of time. In April 2019, Pacira acquired the iovera°® system, a handheld cryoanalgesia device used to deliver precise, controlled doses of cold temperature only to targeted nerves. To learn more about Pacira, including the corporate mission to reduce overreliance on opioids, visit www.pacira.com.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.